NCT07322653 The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
| NCT ID | NCT07322653 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nuritas Ltd |
| Condition | Sarcopenia in Elderly |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-09-10 |
| Primary Completion | 2026-10-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia
Eligibility Criteria
Inclusion Criteria: * 60 years or older * BMI ≤ 25 kg/m² * Malnourished (mini nutritional assessment MNA \<11 * Sarcopenic: SARC-F score ≥ 4 * Capable or oral feeding either alone or assisted * Ambulatory (WHO PS/ECOG 0-3) * Ability to complete questionnaires and self assess health status * Ability to provide consent Exclusion Criteria: * Patient cannot eat orally * Acute Infection * Proven Intestinal obstruction * Co-morbidities requiring a special diet (diabetes, kidney disease etc.) * Liver dysfunction * Acute or chronic renal failure * Uncontrollable nausea or vomiting * Use of megestrol acetate or metabolic steroids * Dietary supplement use in the last 3 months * Known intolerance or allergy to the investigational products * Participation in any clinical trial within the last 3 months